Styrax Pharma Private Limited

Styrax Pharma Private Limited - pharma in Visakhapatnam, Andhra Pradesh, India. FY 2026 financials & compliance.
CIN U24230AP1995PTC098146 Incorporated 10 July 1995 ROC Vijayawada HQ Visakhapatnam, Andhra Pradesh, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2024
₹260.24 Cr
▲ 4% YoY
Net profit · FY 2024
₹9.16 Cr
Net margin 3.5%
EBITDA · FY 2024
₹29.31 Cr
EBITDA margin 11.3%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹13.12 Cr
Issued & subscribed
Open charges
₹187.82 Cr
Satisfied ₹163.68 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
264
Provident fund records

About Styrax Pharma Private Limited

Data last updated:

Styrax Pharma Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 July 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24230AP1995PTC098146. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹13.12 Cr. It was formerly known as Vaya Jayanthi Drugs Private Limited. It is led by directors including Suryadevara Venkateswara Rao (Managing Director) and Sreenath Suryadevara.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 27B J. N. Pharmacity Parawada Vishakapatnam, Visakhapatnam, Andhra Pradesh, India – 531021.

As per the financials filed for FY 2024, the company reported a revenue of ₹260.24 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹9.16 Cr (net margin 3.5%) and EBITDA of ₹29.31 Cr (EBITDA margin 11.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.

The company has about 264 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Styrax. As per MCA filings, the company has open charges of ₹187.82 Cr and satisfied charges of ₹163.68 Cr on record. Court records list 11 cases involving the company, including 2 filed by the company and 9 filed against it; 8 cases are pending. The company has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021. Its 5 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Sodium Metal Pvt Ltd with revenue of ₹273.32 Cr.

Styrax Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0000436). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website styraxpharma.com.

Company details

CIN U24230AP1995PTC098146
Registration Number 098146
Incorporation Date 10 July 1995
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-AP-10-0000436

CIN history

Styrax Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24230AP1995PTC098146, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230AP1995PTC098146Current
U24230TG1995PTC020995Previous
U24230AP1995PTC020995Previous

Recognitions & Rankings of Styrax Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-AP-10-0000436

Contact details

Styrax Pharma Private Limited's registered office is in Visakhapatnam, Andhra Pradesh. Its website is styraxpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No. 27B J. N. Pharmacity Parawada Vishakapatnam, Visakhapatnam, Andhra Pradesh, India – 531021
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Styrax Pharma Private Limited, buy the company report.

Comprehensive company report
Styrax Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Styrax Pharma operates one associated brand: Styrax. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturer & supplier of active pharmaceutical ingredients and intermediatesstyraxpharma.com

Business activity

The main business activity of Styrax Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Styrax Pharma Private Limited, buy the company report.

Financials of Styrax Pharma Private Limited

FY 2025 filings available

Styrax Pharma Private Limited reported revenue of ₹260.24 Cr (up 4% YoY) for FY 2024.

Revenue · FY 2024
₹260.24 Cr ▲ 4%
Net profit · FY 2024
₹9.16 Cr margin 3.5%
EBITDA · FY 2024
₹29.31 Cr margin 11.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 6%

Revenue rose 4% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹29.31 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹9.16 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin11.3%
Net Profit Margin3.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Styrax Pharma Private Limited, buy the company report.

Board of directors of Styrax Pharma Private Limited

Styrax Pharma has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sreenath SuryadevaraDirector18 Apr 20197 Years 7 MonthsCurrent
Lakshmi Devi SuryadevaraDirector18 Apr 20197 Years 7 MonthsCurrent
Suryadevara Venkateswara RaoManaging Director23 Jun 201412 Years 4 MonthsCurrent

Peer comparison

Styrax Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sodium Metal Pvt Ltd₹273.32 Cr (FY 2023)-11.0%Vadodara, Gujarat, India
Saraf Chemicals Private Limited₹271.96 Cr (FY 2025)16.0%Mumbai, Maharashtra, India
Styrax Pharma Private Limitedthis company₹260.24 Cr (FY 2024)₹9.16 Cr3.5%4.0%264Visakhapatnam, Andhra Pradesh, India
Rakshit Drugs Private Limited₹256.13 Cr (FY 2024)-3.0%Hyderabad, Telangana, India
East India Pharmaceutical Works Limited₹249.94 Cr (FY 2024)Kolkata, West Bengal, India
Rakshit Pharmaceuticals Limited₹238.14 Cr (FY 2024)-6.0%Hyderabad, Telangana, India

To see the full peer comparison of Styrax Pharma Private Limited, buy the company report.

Auditor

Styrax Pharma Private Limited is audited by V.M.G.K. MURTY & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
V.M.G.K. MURTY & COFY 2023002223S

Shareholding

The shareholding of Styrax Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Styrax Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹187.82 Cr
Satisfied charges
₹163.68 Cr
Breakdown by lending institutions
Others₹80.00 Cr
Hdfc Bank Limited₹64.90 Cr
Yes Bank Limited₹21.50 Cr
Axis Bank Limited₹21.42 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
04 Oct 2023100803552Others₹45 CrOpen
29 Mar 2023100704273Yes Bank Limited₹1.5 CrOpen
29 Mar 2023100706996Yes Bank Limited₹20 CrOpen
23 Mar 2023100706999Axis Bank Limited₹20.8 CrOpen
01 Mar 2023100682072Others₹35 CrOpen

To see the full charge records of Styrax Pharma Private Limited, buy the company report.

Total charge records: 26 View all charges

Deals & funding

Styrax Pharma Private Limited has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021.

Total deals
10
Secondary share transfers
6
Funding rounds
3
Rights issue
1
Disclosed funding
₹15.8 Cr

Deals on record (5 of 10)

WhenDealAmountParties
Mar 2021Secondary share transferUndisclosedBuyer: an individual
Seller: Aurore Life Sciences Private Limited
Jul 2017Rights issue₹17.71 CrInvestors: Aurore Life Sciences Private Limited
Nov 2015Funding round₹14 CrInvestors: 4 individuals
Oct 2015Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals
Mar 2014Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 4 individuals

To see the full deal history of Styrax Pharma Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Styrax Pharma Private Limited was last rated by Care on 02 Nov 2021.

Rating agencyRated onRating
Care02 Nov 2021

To see the full credit ratings and regulatory alerts of Styrax Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Styrax Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Styrax Pharma Private Limited has a workforce of 264 employees on its EPFO records as of Feb 2025, across 1 active EPFO establishment.

Employee count
264
Active EPFO establishments
1

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2024-25264
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Styrax Pharma Private Limited, buy the company report.

GST

Styrax Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Styrax Pharma Private Limited, buy the company report.

Recent activity

Styrax Pharma Private Limited has 11 board changes on record since 2008: 3 appointments and 8 cessations. The latest: Sreenath Suryadevara ceased to be Additional Director on 30 Sep 2019.

AGM
Styrax Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 35.00 Cr registered on 01 Mar 2023 with Charge ID 100682072 was modified on 23 Apr 2025.
Filing
Styrax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Charges
A charge registered on 17 Jul 2023 via Charge ID 100749047 with Others was fully satisfied on 28 Mar 2025.
Charges
A charge with Others of Rs. 45.00 Cr registered on 04 Oct 2023 with Charge ID 100803552 was modified on 29 Nov 2024.
Charges
A charge registered on 31 Mar 2021 via Charge ID 100440801 with Others was fully satisfied on 16 Oct 2024.
Charges
A charge registered on 18 Nov 2019 via Charge ID 100305933 with Others was fully satisfied on 16 Oct 2024.
Charges
A charge with Others of Rs. 20.00 Cr registered on 17 Jul 2023 with Charge ID 100749047 was modified on 03 Jul 2024.
Charges
A charge registered on 15 Mar 2022 via Charge ID 100575610 with Others was fully satisfied on 06 Jun 2024.
Charges
A charge registered on 15 Mar 2022 via Charge ID 100575873 with Others was fully satisfied on 06 Jun 2024.
Charges
A charge with Others amounted to Rs. 45.00 Cr with Charge ID 100803552 was registered on 04 Oct 2023.
Charges
A charge registered on 22 Mar 2022 via Charge ID 100571868 with Standard Chartered Bank was fully satisfied on 24 Jul 2023.

60 earlier events are in the company report.

Frequently asked questions

Styrax Pharma is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 July 1995 (31+ years old) and is registered under CIN U24230AP1995PTC098146.

Styrax Pharma has 3 current directors:

The latest financial statements of Styrax Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

No. Styrax Pharma has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Styrax Pharma is U24230AP1995PTC098146. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Styrax Pharma has 11 court cases on record: 2 filed by the company and 9 filed against it. 8 are pending. Most are in the district courts.

Styrax Pharma was incorporated on 10 July 1995, making it 31+ years old. It is registered with the Registrar of Companies, Vijayawada.

Styrax Pharma has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹15.8 Cr; the latest was in March 2021.

The peers of Styrax Pharma by revenue are Sodium Metal Pvt Ltd, Saraf Chemicals Private Limited, Rakshit Drugs Private Limited, East India Pharmaceutical Works Limited, Rakshit Pharmaceuticals Limited, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Sreenath Suryadevara ceased to be Additional Director on 30 Sep 2019. Lakshmi Devi Suryadevara was appointed as Director on 18 Apr 2019. Rajender Juvvadi Rao ceased to be Director on 18 Apr 2019. Styrax Pharma has 11 board changes on record in total.

Yes, Styrax Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-AP-10-0000436).